Luciene Terezina de Lima

Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia

Luciene Terezina de Lima, Douglas Vivona, Carolina Tosin Bueno et al. · Medical Oncology · 2014 · 40 citations · Full text

Hematological Malignancy, Tumor Biology, Chronic Myeloid Leukemia +8

ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib

Douglas Vivona, Luciene Terezina de Lima, Alice Cristina Rodrigues et al. · Oncology Letters · 2014 · 39 citations · Full text

ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib

Douglas Vivona, Carolina Tosin Bueno, Luciene Terezina de Lima et al. · Blood Cells Molecules and Diseases · 2011 · 38 citations · Full text

Hematological Malignancy, Oncology, Medicine +11

Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients

Luciene Terezina de Lima, Carolina Tosin Bueno, Douglas Vivona et al. · Hematology · 2014 · 28 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Immunology +17

CALR mutations screening in wild type JAK2V617F and MPLW515K/L Brazilian myeloproliferative neoplasm patients

Daniela Prudente Teixeira Nunes, Luciene Terezina de Lima, Maria de Lourdes Chauffaille et al. · Blood Cells Molecules and Diseases · 2015 · 19 citations · Full text

Hematological Malignancy, Tumor Biology, Medicine +10